Pierre and Marie Curie University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Paris France (1971)

Organization Overview

First Clinical Trial
2004
NCT00236275
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Digestive Surgery, Saint-Antoine Hospital, Hospital of Paris (AP/HP), Pierre et Marie Curie University, 184 rue du Faubourg Saint-Antoine, 75012 Paris, France | Pierre and Marie Curie University | Unit 1136 INSERM, Faculty of medecine, University Pierre and Marie Curie | Université Paris 6 Pierre et Marie Curie | University of Pierre et Marie Curie | University PMCurrie-INSERM

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenoma (Phase 3)

Adenomatous Polyposis Coli (Phase 3)

Breast Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Diarrhea (Phase 4)

HIV Infections (Phase 4)

Inflammatory Bowel Diseases (Phase 3)

Intestinal Diseases (Phase 3)

Malabsorption Syndromes (Phase 4)

Nasopharyngeal Neoplasms (Phase 3)

Neoplasms (Phase 2)

Respiratory Insufficiency (Phase 4)

Suicide (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 17